Live Breaking News & Updates on Carol Aghajanian

Stay updated with breaking news from Carol aghajanian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Addition of Up-front Durvalumab, Maintenance Olaparib to Standard Therapy Improves PFS in Advanced Ovarian Cancer

The addition of durvalumab to standard upfront therapy with chemotherapy and bevacizumab followed by maintenance bevacizumab, durvalumab, and olaparib led to a statistically significant improvement in progression-free survival compared with chemotherapy and bevacizumab alone in patients with newly diagnosed, advanced ovarian cancer without a BRCA1/2 mutation. ....

Carol Aghajanian , Gynecologic Medical Oncology Service , Memorial Sloan Kettering Cancer Center , 2023 Asco Annual Meeting , Asco Annual Meeting ,